
AbClon Inc. — Investor Relations & Filings
AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기업설명회(IR)개최 | 2020-05-13 | Korean | |
| 기타경영사항(특허권취득)(자율공시)(안정성이 개선된 HER2에 특이적으로 결합하는 항체) | 2020-04-09 | Korean | |
| 정기주주총회결과 | 2020-03-24 | Korean | |
| 사업보고서 (2019.12) | 2020-03-24 | Korean | |
| 기타경영사항(특허권취득)(자율공시)(신규한 폴리펩티드(New Polypeptide)) | 2020-03-19 | Korean | |
| 기타경영사항(특허권취득)(자율공시)(신규한 폴리펩티드(New Polypeptide)) | 2020-03-17 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
11 filings
| |||||
| 9584886 | 기업설명회(IR)개최 | 2020-05-13 | Korean | ||
| 9610206 | 기타경영사항(특허권취득)(자율공시)(안정성이 개선된 HER2에 특이적으로 결합하는 항체) | 2020-04-09 | Korean | ||
| 10099932 | 정기주주총회결과 | 2020-03-24 | Korean | ||
| 10099928 | 사업보고서 (2019.12) | 2020-03-24 | Korean | ||
| 10109121 | 기타경영사항(특허권취득)(자율공시)(신규한 폴리펩티드(New Polypeptide)) | 2020-03-19 | Korean | ||
| 10112377 | 기타경영사항(특허권취득)(자율공시)(신규한 폴리펩티드(New Polypeptide)) | 2020-03-17 | Korean | ||
| 10114477 | 감사보고서제출 | 2020-03-16 | Korean | ||
| 10135683 | 주주총회소집공고 | 2020-03-09 | Korean | ||
| 10148522 | 기타경영사항(자율공시)(전환우선주 전환가액 조정) | 2020-02-28 | Korean | ||
| 10159700 | 주주총회소집결의 | 2020-02-20 | Korean | ||
| 10163641 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2020-02-10 | Korean | ||
|
2019
4 filings
| |||||
| 10177617 | 기업설명회(IR)개최 | 2019-12-10 | Korean | ||
| 10177616 | 주주명부폐쇄기간또는기준일설정 | 2019-12-10 | Korean | ||
| 10180080 | 증권발행결과(자율공시)(제3자배정 유상증자) | 2019-11-28 | Korean | ||
| 10183643 | 주요사항보고서(유상증자결정) | 2019-11-14 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AbClon Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15090/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15090 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15090 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15090 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15090}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AbClon Inc. (id: 15090)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.